Steven Horwitz
MD
Associate Attending
👥Biography 个人简介
Steven Horwitz at MSK has been a leading researcher in T-cell lymphomas — a heterogeneous group of rare and aggressive lymphomas with poor outcomes compared to B-cell lymphomas. His work on brentuximab vedotin for CD30+ T-cell lymphomas (including ALCL), HDAC inhibitors (romidepsin, belinostat) for PTCL and CTCL, and clinical trials in these rare diseases has been important for improving outcomes in this underserved lymphoma subtype.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Steven Horwitz 的研究动态
Follow Steven Horwitz's research updates
留下邮箱，当我们发布与 Steven Horwitz（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment